Table 6.  .

Changes from Baseline in VCD of Treated Eyes (Mean ± SD, D), Organized by Lens Type and CZD

CZD (mm)	Lens Type
	–5C/–10P		–10C/–5P
	2-Zone Alone	−10 SV Pretreatment 2 Zone, 5 D (2-Zone, 10d–5d)	2-Zone Alone	−10 SV Pretreatment 2 Zone, 5 D (2-Zone, 10d–5d)
4.5	0.77 ± 0.17	0.84 ± 0.13	0.73 ± 0.23	0.72 ± 0.10
		(0.15 ± 0.17)		(0.13 ± 0.10)
5.5	0.69 ± 0.29	0.35 ± 0.39*	0.75 ± 0.21	0.27 ± 0.29*
		(0.19 ± 0.30)		(0.16 ± 0.21)
6.5	0.55 ± 0.21	0.56 ± 0.38	0.82 ± 0.10	0.72 ± 0.27
		(0.16 ± 0.44)		(0.12 ± 0.30)
7.5	0.76 ± 0.08	0.86 ± 0.12	0.86 ± 0.16	0.92 ± 0.19
		(0.17 ± 0.10)		(0.13 ± 0.24)

Eyes wore either a 2-zone lens as a replacement for a −10 SV lens or for the entire treatment period (2-zone alone; data transposed from Table 3 for comparison). VCD change after an additional 5 days of 2-zone lens treatment is shown in parentheses. Mean VCD growth in untreated fellow eyes from days 10–15 is 0.21 ± 0.14 mm.

^* P < 0.05 comparing to 2-zone alone group.